| Autor: |
Fingrut WB; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY., Scaradavou A; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY., Barker JN; Warren B. Fingrut, MD, MPH, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; Andromachi Scaradavou, MD, Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY; Juliet N. Barker, MBBS, Bone Marrow Transplant and Cellular Therapy Program, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY. |
